Article by David Brown, Lift
Health Canada released their first public recall of a cannabis product since March 2015 today, with the announcement of a Type II recall of 69 lots of product. This is in addition to five lots recalled under a Type III recall in late December of last year.
The recalled products include both dried marijuana and cannabis oil produced between February 1, 2016 and December 16, 2016. The affected lot numbers are listed here.
The public recall notice explains that five product lots in December had tested positive for myclobutanil “and/or” bifenazate. Both of these are unapproved pesticides under Health Canada’s ACMPR. Then, On Jan 9 of this year, OrganiGram initiated a second voluntary recall, this time a Type II recall based on trace amounts of the same pesticide(s) found.
Health Canada lists their three recall types as such
- Type I: a situation in which there is a reasonable probability that the use of, or exposure to, a product will cause serious adverse health consequences or death,
- Type II: a situation in which the use of, or exposure to, a product may cause temporary adverse health consequences or where the probability of serious adverse health consequences is remote, or
- Type III: a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.
Type III recalls do not generally warrant a public recall, but a Type I or II recall does. In the past, Health Canada has issued public recalls for other medical cannabis, but has not detailed if it was a Type I, II or III.